Immunic logo

Immunic

IMUX | NASDAQ
Chart Builder DCF Calculator
$7.23
-$0.29 (-3.86%)
At close: Nov 16, 2026, 4:00 PM ET
$7.23
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
37
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #605/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $98.65M
1D Range
7.21 7.83
52W Range
5.10 16.90

Valuation (TTM)

PE -1.62
PB 0.94
EV/EBITDA 0.26

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $45.00
Loading financial charts...

Profile

Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditi...

Sector Healthcare
Industry Biotechnology
Employees 100
IPO Date Apr 17, 2014
Website imux.com
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$45.00
Upside
+522.41%
Buy (3)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.